K-ras activation generates an inflammatory response in lung tumors

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Oncogene

• Publication date

  2006-03-30

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1038/sj.onc.1209237PMID 16288213
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammation and cancer: the long reach of Ras

  2005cited by this paper
• Identification of bronchioalveolar stem cells in normal lung and lung cancer.

  2005influential reference
• Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis.

  2004influential reference
• Thymocyte emigration is mediated by active movement away from stroma-derived factors.

  2002cited by this paper
• Early restriction of peripheral and proximal cell lineages during formation of the lung

  2002cited by this paper
• Inflammation and cancer

  2002cited by this paper
• Current status of clinical trials of farnesyltransferase inhibitors

  2001cited by this paper
• Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.

  2001cited by this paper
• Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

  2001influential reference
• Somatic activation of the K-ras oncogene causes early onset lung cancer in mice

  2001cited by this paper
• Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene

  2001cited by this paper
• Blocking oncogenic Ras signaling for cancer therapy.

  2001cited by this paper
• Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

  2001influential reference
• MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis.

  2000cited by this paper
• Expression of interleukin-8 promotes neutrophil infiltration and genetic instability in mutatect tumors.

  2000cited by this paper
• MMP-9 Supplied by Bone Marrow – Derived Cells Contributes to Skin Carcinogenesis

  2000cited by this paper
• The Role of CC10 in Pulmonary Carcinogenesis: From a Marker to Tumor Suppression

  2000cited by this paper
• Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis.

  1999cited by this paper
• Biological implications of macrophage infiltration in human tumor angiogenesis

  1999cited by this paper
• Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer.

  1998cited by this paper
• Increasing Complexity of the Ras Signaling Pathway*

  1998cited by this paper
• Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells.

  1998cited by this paper
• Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice.

  1996cited by this paper
• Flow cytometric identification of murine neutrophils and monocytes.

  1996cited by this paper
• Interleukin-8 and the chemokine family.

  1995cited by this paper
• c-myb affects intracellular calcium handling in vascular smooth muscle cells.

  1995cited by this paper
• The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis (*)

  1995cited by this paper
• Stimulus and cell-specific expression of C-X-C and C-C chemokines by pulmonary stromal cell populations.

  1995cited by this paper
• Interleukin-8 and related chemotactic cytokines. The Giles Filley Lecture.

  1994cited by this paper
• Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8

  1991cited by this paper
• The ras oncogenes in human lung cancer.

  1990cited by this paper
• Ras oncogene mediated induction of a 92 kDa metalloproteinase; strong correlation with the malignant phenotype.

  1988cited by this paper

• Mutant KRAS in brain endothelial cells promotes vascular inflammation and impairs vascular integrity in brain arteriovenous malformation.

  2026cites this paper
• Targeting neutrophils for cancer therapy

  2025cites this paper
• Emerging macrophage-based therapies for cancer: a review of preclinical and clinical advances

  2025cites this paper
• Neutrophil Engulfment in Cancer: Friend or Foe?

  2025cites this paper
• Selective inhibition of canonical STAT3 signaling suppresses K-ras mutant lung tumorigenesis and reinvigorates anti-tumor immunity

  2025cites this paper
• Current Strategies and Future Dimensions in the Development of KRAS Inhibitors for Targeted Anticancer Therapy

  2025cites this paper
• Multifaceted roles of heparin and its derivatives in inflammation and cancer: Mechanisms, clinical applications, and future directions.

  2025cites this paper
• The Role of Blood Inflammatory Markers in Salivary Gland Carcinoma: A Scoping Review

  2025cites this paper
• KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancer.

  2025cites this paper
• Recent Progress and Potential of G4 Ligands in Cancer Immunotherapy

  2025cites this paper
• Shaping the battlefield: EGFR and KRAS tumor mutations’ role on the immune microenvironment and immunotherapy responses in lung cancer

  2025cites this paper
• Exploiting the therapeutic implications of KRAS inhibition on tumor immunity.

  2024cites this paper
• Revisiting 'Hallmarks of Cancer' In Sarcomas

  2024cites this paper
• The next-generation KRAS inhibitors…What comes after sotorasib and adagrasib?

  2024cites this paper
• Targeting KRAS and SHP2 signaling pathways for immunomodulation and improving treatment outcomes in solid tumors.

  2024cites this paper
• MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer

  2024cites this paper
• CXCR1/2 antagonism inhibits neutrophil function and not recruitment in cancer

  2024cites this paper
• Immune status and combined immunotherapy progression in Kirsten rat sarcoma viral oncogene homolog (KRAS)-mutant tumors.

  2024cites this paper
• Cytosolic DNA sensor AIM2 promotes KRAS‐driven lung cancer independent of inflammasomes

  2024cites this paper
• Unveiling the immune symphony: decoding colorectal cancer metastasis through immune interactions

  2024cites this paper
• Cell of origin alters myeloid-mediated immunosuppression in lung adenocarcinoma

  2024cites this paper
• Long-term exposure to house dust mites accelerates lung cancer development in mice

  2023cites this paper
• Prediction of anti-TNF therapy failure in ulcerative colitis patients by ensemble machine learning: A prospective study

  2023cites this paper
• Facts and Hopes on RAS Inhibitors and Cancer Immunotherapy

  2023cites this paper
• Development of alternative herbals remedy for gastric cancer based on transcriptomic analysis of immune infiltration and ferroptosis

  2023cites this paper
• Management of Oncogene Driven Locally Advanced Unresectable Non-small Cell Lung Cancer

  2023cites this paper
• At the crossroads of immunotherapy for oncogene-addicted subsets of NSCLC

  2023cites this paper
• Alveolar macrophages in lung cancer: opportunities and challenges

  2023cites this paper
• Niche-mediated repair of airways is directed in an occupant-dependent manner

  2022cites this paper
• Cell Type-Specific Roles of STAT3 Signaling in the Pathogenesis and Progression of K-ras Mutant Lung Adenocarcinoma

  2022cites this paper
• Cytokine‐ and chemokine‐induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy

  2022cites this paper
• Targeting Scavenger Receptors in Inflammatory Disorders and Oxidative Stress

  2022cites this paper
• RAS: Circuitry and therapeutic targeting.

  2022cites this paper
• Targeting IL-1β as an immunopreventive and therapeutic modality for K-ras–mutant lung cancer

  2022cites this paper
• Circadian disruption enhances HSF1 signaling and tumorigenesis in Kras-driven lung cancer

  2022cites this paper
• The Role of the Tumor Microenvironment and Treatment Strategies in Colorectal Cancer

  2021influential citation
• Oncogenic dependency on STAT3 serine phosphorylation in KRAS mutant lung cancer

  2021cites this paper
• Targeting mutated GTPase KRAS in tumor therapies.

  2021cites this paper
• Analysis of the role of METTL5 as a hub gene in lung adenocarcinoma based on a weighted gene co-expression network.

  2021cites this paper
• The MYC oncogene — the grand orchestrator of cancer growth and immune evasion

  2021cites this paper
• Preclinical Models for the Study of Lung Cancer Pathogenesis and Therapy Development.

  2021cites this paper
• mTORC1 is a mechanosensor that regulates surfactant function and lung compliance during ventilator-induced lung injury

  2021cites this paper
• Inhibition of Granulocytic Myeloid-Derived Suppressor Cells Overcomes Resistance to Immune Checkpoint Inhibition in LKB1-Deficient Non–Small Cell Lung Cancer

  2021cites this paper
• The Combination of Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio with Liquid Biopsy Biomarkers Improves Prognosis Prediction in Metastatic Pancreatic Cancer

  2021cites this paper
• Pulmonary Inflammation and KRAS Mutation in Lung Cancer.

  2021cites this paper
• Therapeutic KRASG12C inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers

  2021cites this paper
• Targeting KRAS: The Elephant in the Room of Epithelial Cancers

  2021cites this paper
• Immune Resistance in Lung Adenocarcinoma

  2021cites this paper
• The Importance of Being PI3K in the RAS Signaling Network

  2021cites this paper
• Impact of cancer cell-intrinsic features on neutrophil behavior.

  2021cites this paper
• Alkaline phosphatase, lactic dehidrogenase, inflammatory variables and apparent diffusion coefficients from MRI for prediction of chemotherapy response in osteosarcoma. A cross sectional study

  2021cites this paper
• AGO2 promotes tumor progression in KRAS-driven mouse models of non–small cell lung cancer

  2021cites this paper
• Low RECK Expression Is Part of the Cervical Carcinogenesis Mechanisms

  2021cites this paper
• Enhanced Vulnerability of LKB1-Deficient NSCLC to Disruption of ATP Pools and Redox Homeostasis by 8-Cl-Ado

  2021cites this paper
• The uses of platelet indices, NLR (Neutrophil to Lymphocyte Ratio) and PLR (Platelet to Lymphocyte Ratio) in the predictive value diagnosis of benign and malignant masses of the parotid gland

  2021cites this paper
• Lung carcinomas induced by NNK and LPS.

  2021cites this paper
• Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas.

  2020cites this paper
• Desmoplasia and Biophysics in Pancreatic Ductal Adenocarcinoma: Can We Learn From Breast Cancer?

  2020cites this paper
• Understanding the Complexity of the Tumor Microenvironment in K-ras Mutant Lung Cancer: Finding an Alternative Path to Prevention and Treatment

  2020influential citation
• Biology and therapeutic targeting of tumour‐associated macrophages

  2020cites this paper
• Good cops turn bad: The contribution of neutrophils to immune-checkpoint inhibitor treatment failures in cancer.

  2020cites this paper
• Analysis of prognostic factors in soft tissue sarcoma: Cancer registry from a single tertiary hospital in Indonesia. A retrospective cohort study

  2020cites this paper
• Mechanosensitive activation of mTORC1 mediates ventilator induced lung injury during the acute respiratory distress syndrome

  2020cites this paper
• Potential Benefits of Bevacizumab Combined With Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Cancer Patients With EGFR Mutation.

  2020cites this paper
• Interplay between Estrogen and Stat3/NF-κB Driven Immunomodulation in Lung Cancer.

  2020cites this paper
• Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy

  2019cites this paper
• IL-4Rα expression by airway epithelium and smooth muscle accounts for nearly all airway hyperresponsiveness in murine allergic airway disease.

  2019cites this paper
• CHUK/IKK-α loss in lung epithelial cells enhances NSCLC growth associated with HIF up-regulation

  2019cites this paper
• Targeting ST2 expressing activated regulatory T cells in Kras-mutant lung cancer

  2019cites this paper
• Investigating the role of MyD88-NF-kB signalling in regulating the inflammatory response to the emerging pre-neoplastic cells

  2019cites this paper
• Distinct initiating events underpin the immune and metabolic heterogeneity of KRAS-mutant lung adenocarcinoma

  2019cites this paper
• RAS: Striking at the Core of the Oncogenic Circuitry

  2019cites this paper
• ADAM17 selectively activates the IL‐6 trans‐signaling/ERK MAPK axis in KRAS‐addicted lung cancer

  2019cites this paper
• ADAM17: An Emerging Therapeutic Target for Lung Cancer

  2019cites this paper
• The Combination of MEK inhibitor with Immunomodulatory Antibodies Targeting PD-1 and PD-L1 Results in Prolonged Survival in Kras/p53 -Driven Lung Cancer

  2019cites this paper
• Distinct Spatio-Temporal Dynamics of Tumor-Associated Neutrophils in Small Tumor Lesions

  2019cites this paper
• LKB1 and KEAP1/NRF2 pathways cooperatively promote metabolic reprogramming with enhanced glutamine dependence in KRAS-mutant lung adenocarcinoma.

  2019cites this paper
• The Combination of MEK Inhibitor With Immunomodulatory Antibodies Targeting Programmed Death 1 and Programmed Death Ligand 1 Results in Prolonged Survival in Kras/p53-Driven Lung Cancer.

  2019cites this paper
• Profiling of differentially expressed genes in cadmium-induced prostate carcinogenesis.

  2019cites this paper
• The Predictive Value of Neutrophil-to-Lymphocyte Ratio for Hodgkin’s Lymphoma Diagnosis in Patients with Asymptomatic Cervical Lymphadenopathy

  2019cites this paper
• Fall 10-26-2012 Mucin ( Muc ) expression during pancreatic cancer progression in spontaneous mouse model : potential implications for diagnosis and therapy

  2019cites this paper
• Clinical significance of traditional clinical parameters and inflammatory biomarkers for the prognosis of patients with spinal chondrosarcoma: a retrospective study of 150 patients in a single center

  2019cites this paper
• From immune checkpoints to vaccines: The past, present and future of cancer immunotherapy.

  2019cites this paper
• Respiratory Enterovirus (like Parainfluenza Virus) Can Cause Chronic Lung Disease if Protection by Airway Epithelial STAT1 Is Lost

  2019cites this paper
• Development of a novel AOP for Cyp2F2-mediated Lung Cancer in Mice.

  2019cites this paper
• Targeting the Tumor Microenvironment: An Unexplored Strategy for Mutant KRAS Tumors

  2019cites this paper
• Cxcr1 mediates recruitment of neutrophils and supports proliferation of tumor-initiating astrocytes in vivo

  2018cites this paper
• Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion

  2018cites this paper
• Association between angiogenesis and cytotoxic signatures in the tumor microenvironment of gastric cancer

  2018cites this paper
• Epigenetically distinct sister chromatids and asymmetric generation of tumor initiating cells

  2018cites this paper
• IL22 Promotes Kras-Mutant Lung Cancer by Induction of a Protumor Immune Response and Protection of Stemness Properties

  2018cites this paper
• Cancer‐Cell‐Intrinsic Mechanisms Shaping the Tumor Immune Landscape

  2018cites this paper
• Kras and Tumor Immunity: Friend or Foe?

  2018influential citation
• Modulation of Lung Epithelial Cell Function Using Conditional and Inducible Transgenic Approaches.

  2018cites this paper
• De novo lipogenesis represents a therapeutic target in mutant Kras non‐small cell lung cancer

  2018cites this paper
• Cellular Biomarker for the Responding of Anti-PD-1 Therapy in Non-Small Cell Lung Cancer Patients

  2018cites this paper
• Prognostic value of inflammation-based indexes for intrahepatic cholangiocarcinoma following curative resection

  2018cites this paper
• Targeting IL22: a potential therapeutic approach for Kras mutant lung cancer?

  2018cites this paper
• Germline control of somatic Kras mutations in mouse lung tumors

  2018cites this paper
• KRAS Oncogenic Signaling Extends beyond Cancer Cells to Orchestrate the Microenvironment.

  2018cites this paper